E-083 Intraarterial and intravenous abciximab for management of acute in-situ thrombosis during pipeline flow diversion of intracranial aneurysms
Conclusions
IA and IV ReoPro administration is a effective and safe strategy for the management of acute in-situ thrombosis during PED, with high rates of immediate thrombosis resolution and relatively low rates of hemorrhagic complications and long term morbidity.
Disclosures:
B. Jiang: None. J. Campos: None. N. Beaty: None. E. Westbroek: None. M. Bender: None. R. Tamargo: None. J. Huang: 2; C; Longeviti. G. Colby: 1; C; Stryker. 2; C; Microvention, Medtronic. A. Coon: 2; C; Medtronic, Microvention, Sequent, Stryker. L. Lin: None.
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Jiang, B., Campos, J., Beaty, N., Westbroek, E., Bender, M., Tamargo, R., Huang, J., Colby, G., Coon, A., Lin, L. Tags: Electronic Poster Abstracts Source Type: research
More News: Abciximab | Angiography | Brain | Clopidogrel | Neurology | Neurosurgery | Plavix | Radiography | Thrombosis